CJC-1295 No DAC + Ipamorelin is supplied as a lyophilized vial combining a GHRH analog with a selective growth hormone secretagogue for laboratory research. Available in 5mg/5mg strength with lot-coded traceability and tamper-evident packaging.
CJC-1295 No DAC + Ipamorelin is supplied as a lyophilized vial combining a GHRH analog with a selective growth hormone secretagogue for laboratory research. Available in 5mg/5mg strength with lot-coded traceability and tamper-evident packaging.
$66.99
This formulation combines CJC-1295 No DAC (also known as Modified GRF 1-29), a growth hormone-releasing hormone (GHRH) analog, with Ipamorelin, a selective growth hormone secretagogue that engages the ghrelin receptor. Each compound is studied independently in the GH-axis research literature, and this combination is supplied for laboratories investigating their combined signaling effects. Supplied as a lyophilized powder in a sealed 5mg/5mg vial, with lot-coded traceability and tamper-evident packaging carried through fulfillment.
In laboratory literature, this combination pairs a GHRH analog (CJC-1295 No DAC) with a selective ghrelin-receptor secretagogue (Ipamorelin), with research interest centered on combined growth hormone-axis signaling.
A lyophilized (freeze-dried) powder in a sealed glass vial, ready for reconstitution per your lab’s protocol.
Yes — third-party content verification for both CJC-1295 No DAC and Ipamorelin in the current lot is published above.
Every vial carries an internal lot code tied to our traceability log, plus tamper-evident sealing maintained from fulfillment through delivery.
No. This product is sold strictly for laboratory research use by qualified researchers, and is not a drug, dietary supplement, or medical device.
Orders are prepared from lot-tracked inventory and shipped in tamper-evident packaging with tracking information.
Join our research newsletter for early access to new compounds and COA updates. We'll send a one-time 10% discount code to your inbox.
Research use only (RUO). No spam — unsubscribe anytime.